Piper Sandler Initiates Coverage On LeonaBio with Overweight Rating, Announces Price Target of $20

LeonaBio, Inc.

LeonaBio, Inc.

LONA

0.00

Piper Sandler analyst Kelsey Goodwin initiates coverage on LeonaBio (NASDAQ: LONA) with a Overweight rating and announces Price Target of $20.